Pierre Gagnon
Geen lopende functies
Vermogen: - $ op 31-05-2024
Profiel
Mr. Pierre Gagnon is a Chief Operating Officer at NKGen Biotech, Inc. He is on the Board of Directors at ATGen Canada, Inc. Mr. Gagnon was previously employed as a Chief Operating Officer by NKGen Biotech, Inc. /US/ and a Director-Global Operations & Director by NKMAX Co., Ltd.
He received his undergraduate degree from the University of Quebec.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
-.--% | 29-04-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Pierre Gagnon
| Bedrijven | Functie | Begin |
|---|---|---|
| ATGen Canada, Inc. | Directeur/Bestuurslid | 01-05-2013 |
Eerdere bekende functies van Pierre Gagnon
| Bedrijven | Functie | Einde |
|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Operationeel Directeur | 01-09-2023 |
NKMAX Co., Ltd.
 NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Operationeel Directeur | 01-06-2019 |
Opleiding van Pierre Gagnon
| University of Quebec | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Health Technology |
| ATGen Canada, Inc. |
